ARK Invest Reenters Nvidia, Expands Crypto and Biotech Holdings
Cathie Wood’s ARK Invest made its first Nvidia purchase since August, acquiring 93,374 shares worth $17.5 million on November 20. The move followed Nvidia’s strong Q3 earnings beat, though shares closed 3.2% lower post-report.
ARK diversified into crypto assets (Bullish, Circle Internet, Bitmine Immersion) and biotech (Recursion Pharma, CRISPR Therapeutics), while continuing to shed AMD and Exact Sciences positions. The Exact Sciences selloff came after Abbott’s $21 billion acquisition announcement.
Nvidia’s earnings-driven volatility highlights ARK’s conviction in AI infrastructure plays. The fund’s simultaneous crypto bets signal continued institutional interest in digital assets amid market turbulence.